These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 5032135)
1. Study of the teratogenic potential of diazepam and SCH 12041. Beall JR Can Med Assoc J; 1972 May; 106(10):1061. PubMed ID: 5032135 [No Abstract] [Full Text] [Related]
3. [Use of diazepam in early pregnancy]. Lunde I; Borchgrevink CF Tidsskr Nor Laegeforen; 1976 Jun; 96(17-18):1006. PubMed ID: 950840 [No Abstract] [Full Text] [Related]
4. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Kjaer D; Horvath-Puhó E; Christensen J; Vestergaard M; Czeizel AE; Sørensen HT; Olsen J Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):181-8. PubMed ID: 16941718 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the possible teratogenic effect of bencyclane]. Boissier JR Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1399+. PubMed ID: 5536653 [No Abstract] [Full Text] [Related]
6. Drug-associated congenital abnormalities? Istvan EJ Can Med Assoc J; 1970 Dec; 103(13):1394. PubMed ID: 5492508 [No Abstract] [Full Text] [Related]
7. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Study of teratogenic activity in rabbits and rats. Gaetani M; Debeus R Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:223-6. PubMed ID: 5067197 [No Abstract] [Full Text] [Related]
8. No association found between use of very large doses of diazepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring. Gidai J; Acs N; Bánhidy F; Czeizel AE Toxicol Ind Health; 2008; 24(1-2):29-39. PubMed ID: 18818179 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the teratogenic activity of thalidomide in rabbits and rats. Schumacher H; Blake DA; Gurian JM; Gillette JR J Pharmacol Exp Ther; 1968 Mar; 160(1):189-200. PubMed ID: 5639104 [No Abstract] [Full Text] [Related]
10. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between the placental-fetal index (PFI) and the toxic and teratogenic effect in the fetuses of mothers treated with sedalgin during pregnancy]. Todorov S Eksp Med Morfol; 1983; 22(1):39-43. PubMed ID: 6653478 [No Abstract] [Full Text] [Related]
16. [Examination of the active substances coumarin and rutin in a teratogenic trial with rabbits]. Grote W; Weinmann I Arzneimittelforschung; 1973 Sep; 23(9):1319-20. PubMed ID: 4801228 [No Abstract] [Full Text] [Related]
17. [Malformations in the oto-neuro-ophthalmologic area caused by mother's ingestion of teratogenic substances]. Schowing J Rev Med Suisse Romande; 1980 Mar; 100(3):257-61. PubMed ID: 6771860 [No Abstract] [Full Text] [Related]
18. Neuropharmacologic teratogenesis and neurotransmitter regulation of palate development. Zimmerman EF Am J Ment Defic; 1984 Mar; 88(5):548-58. PubMed ID: 6145355 [TBL] [Abstract][Full Text] [Related]
19. The role of maternal toxicity in lovastatin-induced developmental toxicity. Lankas GR; Cukierski MA; Wise LD Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732 [TBL] [Abstract][Full Text] [Related]